Title : Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer.

Pub. Date : 2017

PMID : 28367059






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer. Niclosamide signal transducer and activator of transcription 3 Homo sapiens
2 In this study, we show that niclosamide can potentially inhibit signal transducer and activator of transcription 3 (STAT3) in colon cancer cell lines. Niclosamide signal transducer and activator of transcription 3 Homo sapiens
3 In this study, we show that niclosamide can potentially inhibit signal transducer and activator of transcription 3 (STAT3) in colon cancer cell lines. Niclosamide signal transducer and activator of transcription 3 Homo sapiens
4 Combined inhibition of epidermal growth factor receptor and STAT3 by erlotinib and niclosamide synergistically induces apoptosis and antiproliferation in colon cancer cell lines. Niclosamide signal transducer and activator of transcription 3 Homo sapiens